Clinical impact of antimicrobial resistance in humans

OIE Revue Scientifique et Technique

Volumn 31, Issue 1, 2012, Pages 211-220

  Collignon, P ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Antibiotic; Antimicrobial resistance; Community onset infection; Escherichia coli Healthcare associated infection; Staphylococcus aureus

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 84864071307     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.31.1.2111     Document Type: Article

References (58)

1. Aarestrup EM., McDermott EE & Wegener H.C. (2008). -Transmission of amimicrobial resistance from food animals to humans. In Campylobacter (1. Nachamkin, C. Szymanski & M. Blaser, eds), 3rd ed. ASM Press, Washington, DC, 645-665.
2. Aarestrup EM., Wegener H.C. & Colhgnon P (2008). -Resistance in bacteria of the food chain: epidemiology and control strategies. Expert Rev. anti-infect. Ther., 6, 733-750.
3. Beidenbach D.J., Moet G.J. & Jones R.N. (2004). -Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (1997-2002). Diagn. Microbiol. infect. Dis., 50, 59-69.
4. Brinas L., Moreno M.A., Zarazaga M., Porrero C., Sáenz Y, García M., Domínguez L. & Torres C. (2003). - Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coh fecal-sample isolates from healthy chickens. Antimicrob. Agents Chemother., 47, 2056-2058. (Pubitemid 36637846)
5. Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) (2007). - Salmonella Heidelberg ceftiofur-related resistance in human and retail chicken isolates. Modified 16 August 2007. Available at: www.phac-aspc.gc.ca/cipars-picra/heidelberg/heidelberg-eng php (accessed on 11 October 2011).
6. Carlet J., Colhgnon R, Goldmann D., Goossens H., Harbarth S., Jariier V, Levy S.B., N'Doye B., Pittet D., Richtmann R., Seto WH., van der Meer J.W & Voss A. (2011). - Society's failure to protect a precious resource: antibiotics. Lancet, 378, 369-371.
7. Cavaco L.M., Abatih E., Aarestrup EM. & Guardabassi L. (2008). - Selection and persistence of CTX-M-producing Escherichia coh in the intestinal flora of pigs treated with amoxiciUin, ceftiofur or cefquinome. Antimicrob. Agents Chemother., 52, 3612-3616.
8. Coelho J.M., Turton J.E, Kaufmann M.E., Glover J., Woodford N., Warner M., Palepou M., Pike R., Pitt TL, Patel B.C. & Livermore D.M. (2006). - Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and southeast England. J. din. Microbiol, 44, 3623-3627. (Pubitemid 46768804)
9. Colhgnon R & Angulo EJ. (2006). - Eluoroquinolone-resistant Escherichia coli: food for thought. J. infect. Dis., 194 (1), 8-10.
10. Colhgnon R, Courvahn R & Aidara-Kane A. (2008). -Clinical importance of antimicrobial drugs to human health. Chapter 4. In Guide to antimicrobial use in animals (L. Guardabassi, L. Jensen & H. Kruse, eds). Blackwell, Oxford.
11. Colhgnon P., Dreimanis D. & Ferguson J. (2008). -Bloodstream infections. In Reducing harm to patients from healthcare associated infection: the role of surveillance. Australian Commission on Safety and Quahty in Health Care (M. Cruickshank & J. Ferguson, eds), 53-89. Available at: www.health.gov.au/internet/safety/pubhshing.nsi/Content/ prog-HAI-Surveillance (accessed on 8 August 2011).
12. Colhgnon R, Nimmo G.R., Gottheb T. & Gosbell L.B. (2005). - Australian Group on Antimicrobial Resistance. Staphylococcus aureus bacteremia, Australia. Emerg. infect. Dis., 11, 554-561. Available at: www.cdc.gov/ncidod/ eid/volllno 04/pdfs/04-0772.pdf (accessed on 8 August 2011).
13. Colhgnon R, Powers J.H., Chiller T.M., Aidara-Kane A. & Aarestrup FM. (2009). - World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies for the use of antimicrobials in food production animals. Üin. infect. Dis., 49 (1), 132-141.
14. Colhgnon RJ. & Tumidge J.D. (2000). - Antibiotic resistance in Streptococcus pneumoniae. Med. J. Aust., 173 (Suppl.), S58-64.
15. Corpet D.E. (1988). - Antibiotic resistance from food. N. Engl.J. Med., 318, 1206-1207.
16. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber MJ., Karchmer A.W & Carmeli Y. (2003). - Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin, inject. Dis., 36, 53-59. (Pubitemid 36099097)
17. Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP) (2009). - Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Statens Serum Institut, Danish Veterinary and Food Administration, Danish Medicines Agency and Danish Institute for Food and Veterinary Research, Copenhagen. Available at: www.danmap.org/pdfFiles/Danmap-2009.pdf (accessed on 8 August 2011).
18. De Kraker M.E., Wolkewitz M., Davey PG., Koller W, Berger J., Nagler J., Icket C., Kalenic S., Horvatic J., Seifert H., Kaasch A., Paniara O., Argyropoulou A., Bompola M., Smyth E., Skally M., Raglio A., Dumpis U., Melbarde Kelmere A., Borg M., Xuereb D., Ghita M.C., Noble M., Kolman J., Grabljevec S., Tumer D., Lansbury L. & Gmndmann H. (2011). - Burden of antimicrobial resistance in European hospitals: excess mortahty and length of hospital stay associated with bloodstream infections due to Escherichia coh resistant to third-generation cephalosporins. J. antimicrob. Chemother., 66, 398-407.
19. Decousser J.W, Pina P, Picot E, Delalande C., Pangon B., Courvalin P, Allouch P & ColBVH Study Group (2003). -Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey J. antimicrob. Chemother., 51, 1213-1222. (Pubitemid 36622077)
20. Engberg J., Aarestrup EM., Taylor D.E., Gerner-Smidt P & Nachamkin I. (2001). - Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. inject. Dis., 7, 24-34. (Pubitemid 32173330)
21. European Centre for Disease Prevention and Control (ECDC) (2009). - Antimicrobial resistance surveillance in Europe. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC, Stockholm. Available at: wwwecdc.europa.eu/en/publications/ Publications/101 l-SUR-annual-EARS-Net-2009.pdf (accessed on 8 August 2011).
22. Fernando G.A., Colhgnon PJ. & Bell J.M. (2010). - A risk for returned travellers: the 'post-antibiotic era'. Med. J. Aust., 193 (1), 59.
23. Finland M., Jones WE, Jr. & Barnes M.W (1959). -Occurrence of serious bacterial infections since introduction of antibacterial agents. JAMA, 170, 2188-2197.
24. Food and Agriculture Organization of the United Nations/World Organisation for Animal Health/Worid Health Organization (2003). - Joint expert workshop on non-human antimicrobial usage and antimicrobial resistance: scientific assessment, 1-5 December, Geneva. World Health Organization, Geneva. Available at: www.who.int/foodsafety/ publications/micro/en/amr.pdf (accessed on 8 August 2011).
25. Garau J., Xercavins M., Rodriguez-Carballeira M., Gómez-Vera J.R., Coll L., Vidal D., Llovet T. & Ruíz-Bremón A. (1999). - Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob. Agents Chemother., 43, 2736-2741. (Pubitemid 29519557)
26. Health Protection Agency (2009). - Quarteriy results from the mandatory surveillance of MRSA bacteraemia, June. UK Health Protection Agency Available at: www.hpa.org.uk/web/ HPAweb&HPAwebStandard/HPAweb-C/1233906819629 (accessed on 8 August 2011).
27. Heuer O.E., Hammerum A.M., Colhgnon P & Wegener H.C. (2006). - Human health hazard from antimicrobial-resistant enterococci in animals and food. Clin, inject. Dis., 43,911-916. (Pubitemid 44435522)
28. Ho PL, Chow K.H., Lai E.L, Lo WU., Yeung M.K., Chan J., Chan RY. & Yuen K.Y. (2011). - Extensive dissemination of CTX-M-producing Escherichia coh with multidrug resistance to 'critically important' antibiotics among food animals in Hong Kong, 2008-2010. J. antimicrob. Chemother., 66 (4), 765-768.
29. Hsueh R-R., Teng L.-J., Lee L-N., Yang PC., Ho S.W & Luh K.T. (1999). - Dissemination of high-level penicillin-, extended-spectrum cephalosporin-, and erythromycin-resistant Streptococcus pneumoniae clones in Taiwan. J. din. Microbial., 37, 221-224. (Pubitemid 29004213)
30. Huijsdens X.W, van Dijke B.J., Spalburg E., van Santen-Verheuvel M.G., Heck M.E., Pluister G.N., Voss A., Wannet WJ. & de Neeling AJ. (2006). - Community-acquired MRSA and pig-farming. Ann. din. Microbiol. Antimicrob., 5, 26.
31. Hujer K.M., Hujer A.M., Hulten E.A., Bajaksouzian S., Adams J.M., Donskey CJ., Ecker DJ., Massire C., Eshoo M.W, Sampath R., Thomson J.M., Rather RN., Craft D.W, Eishbain J.T., Ewell AJ., Jacobs M.R., Paterson D.L. & Bonomo R.A. (2006). - Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother., 50 (12), 4114-4123. (Pubitemid 44865156)
32. lovine N.M. & Blaser MJ. (2004). - Antibiotics in animal feed and spread of resistant Campylobacter from poultry to humans. Emerg infect. Dis., 10, 1158-1159. (Pubitemid 38697717)
33. Johnson J.R., Kuskowski M.A., Menard M., Gajewski A., Xercavins M. & Garau J. (2006). - Similarity of human and chicken Escherichia coh isolates with relation to ciprofloxacin resistance status.J, infect. Dis., 194, 71-78.
34. Joint Expert Advisory Committee on Antibiotic Resistance OETACAR) (1999). - The use of antibiotics in food-producing animals. Antibiotic-resistant bacteria in animals and humans. Available at: www.health.gov.au/intemet/main/ Pubhshing.nsf/Content/2A8435C711929352CA256E180057 901E/File/jetacar.pdf (accessed on 8 August 2011).
35. Kennedy K. & Colhgnon R (2010). - Colonisation with Escherichia coh resistant to 'critically important' antibiotics: a high risk for intemational travellers. Eur J. din. Microbiol. infect. Dis., 29 (12), 1501-1506.
36. Kennedy KJ., Roberts J.L. & Colhgnon PJ. (2008). -Escherichia coli bacteraemia in Canberra: incidence and chnical features. Med. J Aust., 188, 209-213.
37. Khanna T., Friendship R., Dewey C. & Weese J.S. (2008). -Methicilhn resistant Staphylococcus aureus colonization in pigs and pig farmers. Vet. Microbiol., 128, 298-303. (Pubitemid 351305091)
38. Klevens R.M., Morrison M.A., Nadie J., Petit S., Gershman K., Ray S., Harrison L.H., Lynfield R., Dumyati G., Townes J.M., Craig A.S., Zell E.R., Eosheim G.E., McDougal L.K., Carey R.B. & Eridkin S.K. for the Active Bacterial Core surveillance (ABCs) MRSA Investigators (2007). - Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA, 298, 1763-1771. (Pubitemid 47598444)
39. Kollef M.H. (2008). - Update on the appropriate use of meropenem for the treatment of serious bacterial infections. Gin. infect. Dis., 47 (1), Sl-2.
40. Kumarasamy K.K., Toleman M.A., Walsh T.R., Bagaría J., Butt E, Balakrishnan R., Chaudhary U., Doumith M., Giske C.G., Irfan S., Krishnan R, Kumar A.V, Mahaijan S., Mushtaq S., Noorie T, Paterson D.L., Pearson A., Perry C., Pike R., Rao B., Ray U., Sarma J.B., Sharma M., Sheridan E., Thirunarayan M.A., Turton J., Upadhyay S., Warner M., Welfare W, Livermore D.M. & Woodford N. (2010). -Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet infect. Dis., 9, 597-602.
41. Lewis H.C., Molbak K., Reese C., Aarestrup EM., Selchau M., Sorum M. & Skov R.L. (2008). - Pigs as source of methicillin-resistant Staphylococcus aureus CC398 infections in humans, Denmark. Emerg. infect. Dis., 14, 1383-1388.
42. UJ., Nation R.L, Tumidge J.D., Milne R.W, Coulthard K., Rayner C.R. & Paterson D.L. (2006). - Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet infect. Dis., 6, 589-601.
43. Mead PS., Slutsker L, Dietz V, McCaig LE, Bresee J.S., Shapiro C., Griffin RM. & Tauxe R.V (1999). - Eood-related illness and death in the United States. Emerg. infect. Dis., 5, 607-625. (Pubitemid 29493763)
44. Mesa R.J., Blanc V, Blanch A.R., Cortés R, González J.J., Lavilla S., Miró E., Muniesa M., Saco M., Tórtola M.T, Mirelis B., Coll R, Llagostera M., Prats G. & Navarro E (2006). - Extended-spectrum beta-lactamase-producing Entero-bacteriaceae in different environments (humans, food, animal farms and sewage). J. antimicrob. Chemother., 58,211-215. (Pubitemid 44295011)
45. Moellering R. (2005). - Enterococcus species. Streptococcus bovis and Leuconostoc species. In Principles and practice of infectious diseases (G.L. Mandell, J.E. Bennett & R. Dolin, eds), 6th Ed. Elsevier Churchill Livingstone, Philadelphia, 2411-2422.
46. Pallares R., Liñares J., Vadillo M., Cabellos C., Manresa E, Viladrich RE, Martin R. & Gudiol E (1995). - Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl J. Med., 333, 474-480.
47. Pegues D., Ohl M. & Miller S. (2005). - Salmonella species including Salmonella Typhi. In Principles and practice of infectious diseases (G.L. Mandell, J.E. Bennett & R. Dohn, eds), 6th Ed. Elsevier Churchill Livingstone, Philadelphia, 2636-2654.
48. Power E. (2006). - Impact of antibiotic restrictions: the pharmaceutical perspective. Qin. Microbiol Infect., 12 (Suppl. 5), 25-34.
49. Tângdén T., Cars O., Melhus A. & Lôwdin E. (2010). -Eoreign travel is a major risk factor for colonization with Escherichia coh producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob. Agents Chemother., 54, 3564-3568.
50. Tumbarello M., Spanu T., Di Bidino R., Marchetti M., Ruggeri M., Trecarichi E.M., De Pascale G., Proli E.M., Cauda R., Cicchetti A. & Eadda G. (2010). - Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy Antimicrob. Agents aemother., 54, 4085-4091.
51. Unicomb L., Ferguson J., Riley T.V & Colhgnon P (2003). -Fluoroquinolone resistance in Campylobacter absent from isolates, Austraha. Emerg. infect. Dis., 9, 1482-1483. (Pubitemid 37356229)
52. Walsh T.R., Weeks J., Livermore D.M. & Toleman M.A. (2011). - Dissemination of NDM-1 positive bacteria in the New Delhi environment and its imphcations for human health: an environmental point prevalence study Lancet infect. Dis., 11, 355-362.
53. Wang H. & Chen M. (2005). - China Nosocomial Pathogens Resistance Surveillance Study Group. Surveillance for antimicrobial resistance among chnical isolates of Gram-negative bacteria from intensive care unit patients in China, 1996 to 2002. Diagn. Microbiol. infect. Dis., 51, 201-208. (Pubitemid 40568765)
54. Worid Health Organization (WHO) (2005). - Critically important antibacterial agents for human medicine for risk management strategies of non-human use: report of a WHO working group consultation, 15-18 February, Canberra, Australia. WHO, Geneva. Available at: www.who.int/ foodbome-disease/resistance/amr-feb2005.pdf (accessed on 8 August 2011).
55. Worid Health Organization (WHO) (2007). - Critically important antibacterial agents for human medicine: categorization for the development of risk management strategies to contain antimicrobial resistance due to non-human use. Report of the second WHO Expert Meeting, 29-31 May, Copenhagen. WHO, Geneva. Available at: www.who.int/foodborne-disease/resistance/antimicrobials- human.pdf (accessed on 8 August 2011).
56. Worid Health Organization (WHO) (2009). - WHO list of critically important antimicrobials, 2nd revision. WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance, Copenhagen. Available at: www.who.int/ foodbome-disease/resistance/cia/en/index.html (accessed on 8 August 2011).
57. Zaidi M., McDennott R & Tollefson L. (2008). - Integrated surveillance of antimicrobial-resistant foodbome pathogens in Mexico. In Antimicrobial resistance in zoonotic bacteria and foodbome pathogens. American Society for Microbiology (ASM) Conference, 15-18 June, Copenhagen, Denmark. ASM, Washington, DC.
58. Zhao S., White D.G., McDermott RE, Friedman S., English L, Ayers S., Meng J., Maurer JJ., Holland R. & Walker R.D. (2001). - Identification and expression of cephamycinase bla (CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob. Agents aemother., 45, 3647-3650. (Pubitemid 33107899)